Steph & CO Bio Rad Laboratories, Inc. Transaction History

Steph & CO

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 27, 2021	SELL	$576.64 - $649.04 $140,700 - $158,365	-244 Closed	0 $0
Q4 2020 Jan 29, 2021	SELL	$510.68 - $643.45 $27,576 - $34,746	-54 Reduced 18.12%	244 $142,000
Q3 2020 Oct 27, 2020	SELL	$454.43 - $535.6 $37,263 - $43,919	-82 Reduced 21.58%	298 $154,000
Q2 2020 Jul 15, 2020	SELL	$334.87 - $493.06 $23,440 - $34,514	-70 Reduced 15.56%	380 $172,000
Q1 2020 Apr 14, 2020	BUY	$320.01 - $409.07 $17,920 - $22,907	56 Added 14.21%	450 $158,000
Q4 2019 Feb 24, 2020	BUY	$319.73 - $374.2 $125,973 - $147,434	394 New	394 $146,000

453

18.2M

19.5K

13.9K

Ticker BIO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,633,900
Market Cap $8.88B
Description
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...

Get notified when there are updates to the investment portfolio of Steph & CO, based on Form 13F filings with the SEC.

Stay updated on Steph & CO with notifications on news.